JILL COLLINS: Open Payments
NPI 1336487412 · HOLTON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 13 payments from 8 companies in 2025. Trend: 2023 $173 · 2024 $150 · 2025 $250
Food & beverage: $250
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $61 |
| Viatris Specialty LLC | 2 | $46 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $31 |
| Amgen Inc. | 2 | $28 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: LEQVIO, YUPELRI, Qelbree, Wegovy, MOUNJARO, EVENITY, CAPLYTA, OTEZLA.
Industry payments across KS — which companies pay providers there.
